Trial Details

TERMINATED
Basic Information
Clinical ID c4195
Identifier NCT00899678
Trial Title The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: Certolizumab Pegol|DRUG: Certolizumab Pegol
Participant Information
Sponsor UCB Celltech
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2009-04
Primary Completion Date 2012-07
Completion Date 2012-07